Recent updates on systemic treatment of atopic dermatitis

被引：0
|
作者：
Ahn, Jiyoung [1 ]
机构：
[1] Natl Med Ctr, Dept Dermatol, 245 Eulji Ro, Seoul 04564, South Korea
来源：
CLINICAL AND EXPERIMENTAL PEDIATRICS | 2024年 / 67卷 / 11期
关键词：
Atopic dermatitis; Biologics; Small mole- cules; Treatment; 2-PHASE; 3; TRIALS; DOUBLE-BLIND; DUPILUMAB TREATMENT; KOREAN PATIENTS; ADULTS; PLACEBO; SAFETY; ADOLESCENTS; PREVALENCE; EFFICACY;
D O I：
10.3345/cep.2024.00339
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Atopic dermatitis (AD) is a complex disease with multifac- torial pathogenesis and variable clinical presentation. Up to one-fifth of patients with AD develop moderate to severe disease that is often refractory to classical therap- ies and can compromise quality of life. This review sum- marizes recent clinical evidence on biological agents and small-molecule immunotherapies for the treatment of AD.
引用
收藏
页码：580 / 588
页数：9
相关论文
共 50 条
  • [1] Updates in atopic dermatitis for the primary care physician: A review of advances in the understanding and treatment of atopic dermatitis
    Choo, Zi-Yi
    Mehlis, Stephanie L.
    Joyce, Joel C.
    DM DISEASE-A-MONTH, 2024, 70 (04):
  • [2] Updated Review on Treatment of Atopic Dermatitis
    Armario-Hita, J. C.
    Galan-Gutierrez, M.
    Dodero-Anillo, J. M.
    Carrascosa, J. M.
    Ruiz-Villaverde, R.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2023, 33 (03) : 158 - 167
  • [3] Emerging Systemic Treatments for Atopic Dermatitis
    Ferrucci, Silvia Mariel
    Tavecchio, Simona
    Marzano, Angelo Valerio
    Buffon, Stefano
    DERMATOLOGY AND THERAPY, 2023, 13 (05) : 1071 - 1081
  • [4] Recent advances in immunomodulators for atopic dermatitis
    Yim, Hyun J.
    Jean, Tiffany
    Ong, Peck Y.
    CURRENT OPINION IN PEDIATRICS, 2023, 35 (06) : 671 - 679
  • [5] Long-term Outcomes of New Systemic Agents in Atopic Dermatitis: Drug Survival Analyses and Treatment Patterns in Daily Practice
    Schlosser, Anne R.
    Nijman, Lars
    Schappin, Renske
    Nijsten, Tamar E. C.
    Hijnen, Dirkjan
    ACTA DERMATO-VENEREOLOGICA, 2025, 105
  • [6] The Diagnosis and Treatment of Atopic Dermatitis
    Holyoak, Keri
    PHYSICIAN ASSISTANT CLINICS, 2023, 8 (04) : 705 - 715
  • [7] Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
    Nogueira, Miguel
    Torres, Tiago
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2021, 11 (04):
  • [8] S3 guideline Atopic dermatitis: Part 2-Systemic treatment
    Werfel, Thomas
    Heratizadeh, Annice
    Aberer, Werner
    Augustin, Matthias
    Biedermann, Tilo
    Bauer, Andrea
    Foelster-Holst, Regina
    Kahle, Julia
    Kinberger, Maria
    Nemat, Katja
    Neustaedter, Irena
    Peters, Eva
    von Kiedrowski, Ralph
    Schmid-Grendelmeier, Peter
    Schmitt, Jochen
    Schwennesen, Thomas
    Simon, Dagmar
    Spindler, Thomas
    Traidl-Hoffmann, Claudia
    Werner, Ricardo Niklas
    Wollenberg, Andreas
    Worm, Margitta
    Ott, Hagen
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 (02): : 307 - 320
  • [9] Upadacitinib for moderate to severe atopic dermatitis
    Navarro-Trivino, Francisco
    Alcantara-Luna, Sara
    Dominguez-Cruz, Javier
    Galan-Gutierrez, Manuel
    Ruiz-Villaverde, Ricardo
    Pereyra-Rodriguez, Jose-Juan
    Armario-Hita, Jose-Carlos
    IMMUNOTHERAPY, 2023, 15 (11) : 799 - 808
  • [10] Treatment of Atopic Dermatitis with Biologic Drugs
    Fabbrocini, Gabriella
    Napolitano, Maddalena
    Megna, Matteo
    Balato, Nicola
    Patruno, Cataldo
    DERMATOLOGY AND THERAPY, 2018, 8 (04) : 527 - 538
12345